FDA Approves PADCEV, KEYTRUDA Combo as First ADC, PD-1 Bladder Cancer Treatment

Retrieved on: 2023-12-16 11:47:02

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves PADCEV, KEYTRUDA Combo as First ADC, PD-1 Bladder Cancer Treatment. View article details on hiswai:

Excerpt

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas")today announced that on December 15, ...

Article found on: www.miragenews.com